Lv31
360 积分 2022-10-02 加入
2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA)
3小时前
已完结
家庭医生互联网医疗健康服务专家共识（2025年）
5天前
已完结
Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT-MAINTAIN
1个月前
已完结
Staging prediabetes and type 2 diabetes: the time to start is now
1个月前
已完结
Leveraging Clinical Pharmacology Data to Assess Biosimilarity and Interchangeability of Insulin Products
1个月前
已完结
Post-marketing safety of Lantus and its interchangeable biosimilar Semglee in the United States: A disproportionality analysis using the FDA Adverse Event Reporting System (FAERS) database
1个月前
已完结
Investigation of Immunogenicity Assessment of Biosimilar Monoclonal Antibodies in the United States
1个月前
已完结
Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open‐Label, Active Comparator Study
1个月前
已完结
An exploratory analysis of glucagon-like peptide-1 (GLP-1) agonists and biosimilars: A literature review
1个月前
已完结
皖公网安备34019202002308
